I. Trajectory
I began in physics at Yıldız Teknik in Istanbul, drawn to the precision
of measurement. A master’s in biomedical engineering at Sorbonne
pulled that machinery toward the body.
At the Paris Brain Institute I spent five years on the anatomo-functional
organization of the subthalamic region with diffusion MRI. The question
that animated my PhD was deceptively simple: when a surgeon places a
DBS electrode in someone with Parkinson’s, which fibres are they
actually engaging?
Answering it pulled me through tractography, phantom-based distortion
evaluation at 1.5 T and 3 T, and the slow, necessary work of
co-designing imaging protocols with the neurosurgeons who would use them.
II. The crossing — academia → industry
In 2022 I joined TheraPanacea as a clinical analyst. Senior scientist
by 2023, manager by 2024. The team now bridges research, product and
regulation across our neurology and radiotherapy programmes.
Much of what I do looks like translation. I translate an F1-score into
a neurologist’s diagnostic question. I translate a regulator’s
clause into a study protocol. I translate a clinical workflow into a
product requirement engineering can implement.
III. What I’m looking for
Conversations with clinicians who want to be useful in shaping a product;
regulators who care about real-world performance; founders building in
clinical AI who need a second pair of trained eyes on validation strategy.
